Arcturus Therapeutics Holdings (ARCT) Receivables - Other (2018 - 2025)
Historic Receivables - Other for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $8.0 million.
- Arcturus Therapeutics Holdings' Receivables - Other fell 7367.13% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 7367.13%. This contributed to the annual value of $4.0 million for FY2024, which is 8760.6% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Receivables - Other stood at $8.0 million for Q3 2025, which was down 7367.13% from $17.2 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Receivables - Other ranged from a high of $92.5 million in Q1 2023 and a low of $2.0 million during Q1 2021
- Over the past 5 years, Arcturus Therapeutics Holdings' median Receivables - Other value was $4.0 million (recorded in 2024), while the average stood at $16.4 million.
- As far as peak fluctuations go, Arcturus Therapeutics Holdings' Receivables - Other skyrocketed by 240563.53% in 2023, and later tumbled by 8760.6% in 2024.
- Over the past 5 years, Arcturus Therapeutics Holdings' Receivables - Other (Quarter) stood at $3.4 million in 2021, then fell by 17.91% to $2.8 million in 2022, then skyrocketed by 1060.06% to $32.1 million in 2023, then tumbled by 87.61% to $4.0 million in 2024, then soared by 100.08% to $8.0 million in 2025.
- Its Receivables - Other stands at $8.0 million for Q3 2025, versus $17.2 million for Q2 2025 and $14.6 million for Q1 2025.